PE20240590A1 - Metodo para producir derivado de difenilmetano - Google Patents

Metodo para producir derivado de difenilmetano

Info

Publication number
PE20240590A1
PE20240590A1 PE2023002240A PE2023002240A PE20240590A1 PE 20240590 A1 PE20240590 A1 PE 20240590A1 PE 2023002240 A PE2023002240 A PE 2023002240A PE 2023002240 A PE2023002240 A PE 2023002240A PE 20240590 A1 PE20240590 A1 PE 20240590A1
Authority
PE
Peru
Prior art keywords
diphenylmethane derivative
crystalline form
produce
produce diphenylmethane
derivative
Prior art date
Application number
PE2023002240A
Other languages
English (en)
Inventor
Hee-Kyoon Yoon
Se-Hwan Park
Ji-Sung Yoon
Soongyu Choi
Hee Jeong Seo
Eun-Jung Park
Younggyu Kong
Kwang-Seop Song
Min Ju Kim
So Ok Park
Original Assignee
Daewoong Pharmaceutical Co Ltd
Green Cross Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daewoong Pharmaceutical Co Ltd, Green Cross Corp filed Critical Daewoong Pharmaceutical Co Ltd
Publication of PE20240590A1 publication Critical patent/PE20240590A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/04Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D9/00Crystallisation
    • B01D9/005Selection of auxiliary, e.g. for control of crystallisation nuclei, of crystal growth, of adherence to walls; Arrangements for introduction thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78Benzo [b] furans; Hydrogenated benzo [b] furans
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13Crystalline forms, e.g. polymorphs
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B51/00Introduction of protecting groups or activating groups, not provided for in the preceding groups
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Referido a una forma cristalina de un compuesto de formula c28; en donde la forma cristalina tiene un espectro de difraccion de rayos X (XRD) que incluye picos en angulos de difraccion (2theta) de 6.2° ± 0.2°, 7.2° ± 0.2°, 8.8° ± 0.2°, 17.6° ± 0.2°, 19.0° ± 0.2°, 22.5° ± 0.2° y 25.1° ± 0.2° en el caso de ser irradiado usando una fuente de luz Cu-Kalpha. Tambien se refiere a un metodo para producir el derivado de difenilmetano, en donde dicha forma cristalina presenta excelentes caracteristicas fisicoquimicas siendo util en la produccion de productos farmaceuticos.
PE2023002240A 2016-06-17 2017-06-15 Metodo para producir derivado de difenilmetano PE20240590A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR20160075910 2016-06-17
PCT/KR2017/006271 WO2017217792A1 (ko) 2016-06-17 2017-06-15 다이페닐메탄 유도체의 제조방법

Publications (1)

Publication Number Publication Date
PE20240590A1 true PE20240590A1 (es) 2024-03-21

Family

ID=60664449

Family Applications (2)

Application Number Title Priority Date Filing Date
PE2023002240A PE20240590A1 (es) 2016-06-17 2017-06-15 Metodo para producir derivado de difenilmetano
PE2018003162A PE20190467A1 (es) 2016-06-17 2017-06-15 Metodo para producir derivado de difenilmetano

Family Applications After (1)

Application Number Title Priority Date Filing Date
PE2018003162A PE20190467A1 (es) 2016-06-17 2017-06-15 Metodo para producir derivado de difenilmetano

Country Status (29)

Country Link
US (2) US10640496B2 (es)
EP (2) EP3663292B1 (es)
JP (4) JP6763978B2 (es)
KR (2) KR102233229B1 (es)
CN (2) CN113651803B (es)
AU (1) AU2017285813B2 (es)
BR (1) BR112018076243A2 (es)
CA (2) CA3081033C (es)
CL (1) CL2018003645A1 (es)
CO (1) CO2018014018A2 (es)
DK (2) DK3663292T3 (es)
DO (1) DOP2018000287A (es)
EC (1) ECSP19000185A (es)
ES (2) ES2898336T3 (es)
HR (1) HRP20211670T8 (es)
HU (1) HUE056428T2 (es)
MA (2) MA44545B2 (es)
MX (2) MX2021008988A (es)
NZ (1) NZ749398A (es)
PE (2) PE20240590A1 (es)
PH (1) PH12018550206A1 (es)
PL (2) PL3663292T3 (es)
PT (2) PT3473621T (es)
RS (1) RS62550B1 (es)
SA (1) SA518400666B1 (es)
SG (2) SG11201811154QA (es)
SI (1) SI3663292T1 (es)
TN (1) TN2018000437A1 (es)
WO (1) WO2017217792A1 (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102011054773A1 (de) 2011-10-25 2013-04-25 Vb Autobatterie Gmbh & Co. Kgaa Anschlusspol für einen Akkumulator, Akkumulatorgehäuse und Maschine zur Herstellung eines Anschlusspols
MX2021001732A (es) * 2018-08-13 2021-06-23 Daewoong Pharmaceutical Co Ltd Preparacion de intermedio util para la sintesis de inhibidor de sglt.
CN112341416A (zh) * 2019-08-09 2021-02-09 天津津艺医药科技发展有限责任公司 一种制备苯并含氧脂杂环衍生物的方法
WO2021172955A1 (ko) 2020-02-27 2021-09-02 주식회사 대웅제약 Sglt 저해제의 합성에 유용한 중간체 및 이를 이용한 sglt 저해제의 제조 방법
CN112094253B (zh) * 2020-09-10 2023-01-10 株式会社大熊制药 用于制备sglt抑制剂中间体的合成方法
US20230322699A1 (en) 2020-09-10 2023-10-12 Daewoong Pharmaceutical Co., Ltd. Synthesis method for preparing sglt inhibitor intermediate
CN113200860A (zh) * 2021-04-29 2021-08-03 爱斯特(成都)生物制药股份有限公司 一种sglt2抑制剂中间体的制备方法
CN113801010A (zh) * 2021-11-18 2021-12-17 山东诚创蓝海医药科技有限公司 一种5-溴-2-氯苯甲酸的制备方法
CN113912487B (zh) * 2021-11-23 2024-05-28 山东研峰新材料科技有限公司 一种2,5-双卤代苯甲酸的合成方法
KR20230110001A (ko) * 2022-01-14 2023-07-21 주식회사 대웅제약 Ssglt 저해제의 합성에 유용한 중간체의 제조 방법
KR20240044190A (ko) 2022-09-28 2024-04-04 주식회사 대웅제약 이나보글리플로진의 신규한 결정형 및 이의 제조방법
KR20240044194A (ko) 2022-09-28 2024-04-04 주식회사 대웅제약 이나보글리플로진의 신규한 공결정

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4966907A (en) * 1988-08-12 1990-10-30 Merck & Co., Inc. 6-substituted 5-hydroxy-2,3-dihydrobenzofurans as inhibitors of leukotriene biosynthesis
DK2896397T4 (da) * 2003-08-01 2020-11-16 Mitsubishi Tanabe Pharma Corp Nye forbindelser med hæmmende aktivitet mod natriumafhængig glukosetransportør
EP2183263B1 (en) 2007-07-26 2011-10-26 Lexicon Pharmaceuticals, Inc. Methods and compounds useful for the preparation of sodium glucose co-transporter 2 inhibitors
AR075262A1 (es) 2008-07-30 2011-03-23 Ferrer Int Compuestos de 1,6-dihidro-2h-3-oxa-6-aza-as-indaceno, proceso para prepararlos, composicion farmaceutica que los comprende, sus usos como medicamentos, o en tratamientos o prevenciones de condiciones asociadas con un funcionamiento alterado de los sistemas regulados por la melatonina, sus usos para
US8163704B2 (en) 2009-10-20 2012-04-24 Novartis Ag Glycoside derivatives and uses thereof
WO2012041898A1 (en) 2010-09-29 2012-04-05 Celon Pharma Sp. Z O.O. Combination of sglt2 inhibitor and a sugar compound for the treatment of diabetes
US9034921B2 (en) * 2011-06-01 2015-05-19 Green Cross Corporation Diphenylmethane derivatives as SGLT2 inhibitors
US9340521B2 (en) * 2013-03-18 2016-05-17 Green Cross Corporation Method for dual inhibition of SGLT1 and SGLT2 using diphenylmethane derivatives
FR3017868A1 (fr) * 2014-02-21 2015-08-28 Servier Lab Derives d'isoquinoleine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Also Published As

Publication number Publication date
SA518400666B1 (ar) 2021-11-30
ES2891825T3 (es) 2022-01-31
MA50774A1 (fr) 2021-03-31
DK3473621T3 (da) 2021-09-06
ES2898336T3 (es) 2022-03-07
JP2023145481A (ja) 2023-10-11
MA50774B1 (fr) 2022-02-28
US10889574B2 (en) 2021-01-12
CL2018003645A1 (es) 2019-03-22
AU2017285813B2 (en) 2020-02-06
RU2021129636A (ru) 2021-11-22
ECSP19000185A (es) 2019-01-31
CA3026756A1 (en) 2017-12-21
SI3663292T1 (sl) 2022-01-31
MX2018015647A (es) 2019-04-11
HRP20211670T8 (hr) 2022-03-18
PL3663292T3 (pl) 2022-01-17
KR20210036892A (ko) 2021-04-05
WO2017217792A1 (ko) 2017-12-21
US20190169174A1 (en) 2019-06-06
JP7352509B2 (ja) 2023-09-28
MA44545A1 (fr) 2019-10-31
EP3663292A1 (en) 2020-06-10
NZ749398A (en) 2020-01-31
US10640496B2 (en) 2020-05-05
CN113651803A (zh) 2021-11-16
JP2021152054A (ja) 2021-09-30
CO2018014018A2 (es) 2019-03-08
TN2018000437A1 (en) 2020-06-15
MA44545B2 (fr) 2020-11-30
RU2019101056A3 (es) 2020-07-17
HUE056428T2 (hu) 2022-02-28
MA44545B1 (fr) 2020-05-29
DK3663292T3 (da) 2021-10-25
EP3663292B1 (en) 2021-09-01
EP3473621B1 (en) 2021-08-04
JP2020117528A (ja) 2020-08-06
KR102379584B1 (ko) 2022-03-29
KR20170142904A (ko) 2017-12-28
SG11201811154QA (en) 2019-01-30
CN109311861A (zh) 2019-02-05
JP2019521985A (ja) 2019-08-08
DOP2018000287A (es) 2019-03-31
JP6763978B2 (ja) 2020-09-30
PT3663292T (pt) 2021-11-08
PH12018550206A1 (en) 2019-09-30
KR102233229B1 (ko) 2021-03-29
CA3026756C (en) 2021-03-02
BR112018076243A2 (pt) 2019-03-26
CN113651803B (zh) 2022-10-28
EP3473621A4 (en) 2020-03-11
HRP20211670T1 (hr) 2022-02-18
CA3081033A1 (en) 2017-12-21
CA3081033C (en) 2022-04-12
US20190382390A1 (en) 2019-12-19
PL3473621T3 (pl) 2022-01-10
MX2021008988A (es) 2022-05-05
EP3473621A1 (en) 2019-04-24
RS62550B1 (sr) 2021-12-31
CN109311861B (zh) 2021-08-24
AU2017285813A1 (en) 2019-01-17
SG10201911782RA (en) 2020-02-27
RU2019101056A (ru) 2020-07-17
PE20190467A1 (es) 2019-04-04
PT3473621T (pt) 2021-10-04

Similar Documents

Publication Publication Date Title
PE20240590A1 (es) Metodo para producir derivado de difenilmetano
CO2019007228A2 (es) Sistemas y métodos para la extracción de productos naturales
EA201400754A2 (ru) Новые фосфатные соединения, способ их получения и фармацевтические композиции, содержащие их
CR20150423A (es) Proceso de fabricación de vortioxetina
AR101368A1 (es) Forma cristalina de sofosbuvir y proceso para su preparación
FR3028671B1 (fr) Diode electroluminescente a puits quantiques dopes et procede de fabrication associe
FR3008644B1 (fr) Procede de fabrication par frittage d'une piece multicouche
FR3002080B1 (fr) Procede de fabrication d'un transistor
CL2018000962A1 (es) Oportunidades para el proceso de aumento de recuperación según se aplica a la producción de molibdeno
MX2016016479A (es) Metodo para producir un pentapeptido sintetico.
FR3052595B1 (fr) Procede de fabrication d'un module photovoltaique
FR3000968B1 (fr) Procede d'elaboration d'un materiau nanocomposite al/tic
FR3008022B1 (fr) Procede de fabrication d'un article optique par imbibition d'un derive de benzotriazole
FR2990445B1 (fr) Procede de fabrication d'un film de cu2znsns4 par silar
AR112337A1 (es) Un método para preparar compuesto de pirimidona
FR3005892B1 (fr) Procede d'obtention d'un article thermoforme
FR3012820B1 (fr) Agrocombustible solide a partir de matieres organiques et son procede de production
FR3004663B1 (fr) Procede de production d'un element multicouche presentant un revetement protecteur
RU2016113163A (ru) Способ производства кормовых дрожжей из торфа
FR3035741B1 (fr) Procede de fabrication d'une cellule photovoltaique.
TH164015A (th) การเตรียมโพลิ แอลฟา-1,3-กลูแคน เอสเตอร์ และฟิล์มที่ผลิตขึ้นจากสารดังกล่าว
AR113760A1 (es) Formas cristalinas
FR3020588B1 (fr) Procede de fabrication d'une structure interieure, ensemble de fabrication correspondant, structure interieure fabriquee selon le procede
FR3009977B1 (fr) Procede de vitrification par gazeification d'une matiere carbonee
PL420085A1 (pl) Sposób wytwarzania 3-n-butylo-4,7-dihydroftalidu